• Join our community
  • Instagram
  • Youtube
  • Facebook
IHH Healthcare Deepens Commitment to Reduce Cancer Burden in Malaysia
08 Jul 2025

Learn how our third memorandum of understanding with Ministry of Health Malaysia is expanding access to life-saving, advanced cancer care at 8 of our hospitals.

 

 

IHH Healthcare Malaysia has inked its third Memorandum of Understanding (MOU) with the Ministry of Health Malaysia, reaffirming our commitment to making advanced cancer treatment accessible to more Malaysians.

The collaboration will fully sponsor radiotherapy and radiosurgery for an additional 500 patients referred from government hospitals. Since its launch in 2022, this public-private initiative has enabled 1,000 cancer patients to receive high-quality treatment at no cost through our Malaysia hospital network.

"This collaboration is a concrete step toward closing the access gap for underserved and lower-income groups. It also reflects Malaysia's broader commitment to Universal Health Coverage, where cancer care is not treated as a privilege but as a right. We should never allow a patient's health outcome to be dictated by where they live or how much they earn,” said Health Minister, YB Datuk Seri Dr Haji Dzulkefly Ahmad during the signing ceremony held at the Malaysia Ministry of Health Multipurpose Hall on 7 July 2025.

This latest agreement will also include Island Hospital Penang, bringing the total number of participating IHH Healthcare Malaysia hospitals to eight. The other seven participating hospitals are Gleneagles Hospital Johor, Gleneagles Hospital Kuala Lumpur, Gleneagles Hospital Penang, Pantai Hospital Ayer Keroh, Pantai Hospital Kuala Lumpur, Pantai Hospital Penang and Prince Court Medical Centre.

"Public-private partnerships play an important role in bridging healthcare gaps, especially for life-threatening illnesses like cancer. By renewing our partnership, we are taking another step forward in our shared mission of making timely, high-quality care more accessible to those who need it most," said IHH Healthcare Chairman Tan Sri Dr Nik Norzrul Thani bin Nik Hassan Thani. 

Under the MOU, patients will be able to receive care at our facilities equipped with advanced technologies such as Gamma Knife and Linear Accelerator (LINAC). These allow for precision tumour targeting while preserving healthy tissue. The initiative also supports the goals outlined in Malaysia’s National Cancer Control Blueprint, particularly the need for earlier intervention and broader access to cancer services.

“Cancer care is not just about cutting-edge equipment. It is also about compassion and commitment. We know the financial burden can be overwhelming, especially in today’s environment. By renewing this MOU, we are reaffirming our role in supporting the public healthcare system and easing that burden where we can," said IHH Healthcare Group CEO Dr Prem Kumar Nair.

“This partnership began with a clear purpose: to close the gap in access to timely, quality cancer care. Treating 1,000 patients so far shows the real impact of that commitment. As we enter this next phase, we remain focused on working with the MOH to ensure more patients receive the care they need, when they need it,” said IHH Healthcare Malaysia CEO Jean-François Naa.

The renewed partnership strengthens our commitment to building a more sustainable healthcare ecosystem. By combining advanced clinical capabilities with our aspiration to Care. For Good., we are catalysing positive change and making quality healthcare more accessible to the communities we serve.

Related Stories

IHH Healthcare Bags Five Wins at the 15th Asian Excellence Awards

Celebrating our leadership, sustainability, and investor relations excellence on the regional stage.

08 Jul 2025
Read More

Fortis CEO Shares Vision for a Healthier India on NDTV

Here is a look at how Fortis is contributing to India’s healthcare transformation.

08 Jul 2025
Read More

IHH Singapore Hits New Digital and Imaging Milestones

Across Singapore, IHH Healthcare is transforming care delivery through data, technology and frontline innovation.

08 Jul 2025
Read More

Parkway Radiology Deploys Annalise.ai Chest X-ray AI Solution

Parkway Radiology has implemented the Annalise.ai Enterprise CXR solution across all its radiology clinics and hospital departments in Singapore. This represents the first network-wide deployment of the chest X-ray AI technology in the country.

08 Jul 2025
Read More

Fortis Enhances Diagnostic and Paediatric Care at S L Raheja Hospital, Mumbai

S L  Raheja Hospital, a Fortis Associate, has significantly expanded its diagnostic and paediatric capabilities with the launch of AI-enabled Digital Positron Emission Tomography–Computed Tomography (PET-CT), 3 Tesla Magnetic Resonance Imaging (MRI), and upgraded Neonatal Intensive Care Unit (NICU) and Paediatric Intensive Care Unit (PICU) services.

08 Jul 2025
Read More
Gleneagles JPMC Kicks Off World Heart Day Brunei Run 2025

Lace Up for a Cause: Gleneagles JPMC Kicks Off Registration for World Heart Day Brunei Run 2025

On 4 June 2025, Gleneagles JPMC officially open registrations for World Heart Day Brunei Run 2025 to champion cardiovascular health awareness

08 Jul 2025
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Parkway Radiology Logo
  • Acibadem Labmed Logo
  • Parkway Laboratories Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo